Xtandi is the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer.
Pharmacists at select Rite Aid stores in California, Maryland, New Hampshire, Nevada and Oregon can now prescribe hormonal contraceptives, improving access for women in these states.
Denine Torr, executive director of the Dollar General Literacy Foundation and Dollar General's vice president of corporate social responsibility and philanthropy, shares how laying the groundwork for literacy can boost community health outcomes.
Allison Bentley, senior director of strategic programs at GNC Health, shares why now is the right time for the global wellness brand to expand into digitized health care.
The FDA has approved Eli LIlly's Zepbound for chronic weight management in adults with obesity, in addition to a reduced calorie diet and increased physical activity.
